Libri sul tema "Heparin"

1960-, Warkentin Theodore E., e Greinacher Andreas, a cura di. Heparin-induced thrombocytopenia. 4^a ed. New York: Informa Healthcare USA, 2007.

1960-, Warkentin Theodore E., e Greinacher Andreas, a cura di. Heparin-induced thrombocytopenia. 3^a ed. New York: Marcel Dekker, 2004.

Warkentin, Theodore E., e Andreas Greinacher. Heparin-induced thrombocytopenia. 4^a ed. New York: Informa Healthcare, 2007.

1960-, Warkentin Theodore E., e Greinacher Andreas, a cura di. Heparin-induced thrombocytopenia. New York: Dekker, 2000.

1960-, Warkentin Theodore E., e Greinacher Andreas, a cura di. Heparin-induced thrombocytopenia. 2^a ed. New York: Dekker, 2001.

Lane, David A., Ingemar Björk e Ulf Lindahl, a cura di. Heparin and Related Polysaccharides. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4899-2444-5.

1949-, Lane D. A., Björk Ingemar e Lindahl Ulf 1939-, a cura di. Heparin and related polysaccharides. New York: Plenum Press, 1992.

Barrowcliffe, Trevor W. Low molecular weight heparin. Chichester, West Sussex, England: Wiley, 1992.

Chang, Shau-Feng. Studies on structure, heparin-binding, and gene expression of hepatic lipase. München: Dissertationsverlag NG Kopierladen, 1993.

institutet, Karolinska, a cura di. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity: Effects of heparin and a low molecular weight heparin fragment (Fragmin®). Stockholm: Acta medica Scandinavica, 1988.

Lever, Rebecca, Barbara Mulloy e Clive P. Page, a cura di. Heparin - A Century of Progress. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-23056-1.

1949-, Machin Samuel J., a cura di. Heparin: Actions, indications & clinical experience. London: Mediq, 1988.

Lantbruksuniversitet, Sveriges, a cura di. Why does Heparin bind antithrombin? Uppsala: Sveriges Lantbruksuniversitet, 1988.

A, Lane David, e Lindahl Ulf, a cura di. Heparin: Chemical and biological properties, clinical applications. London: Arnold, 1989.

Holmer, Erik. Heparin and its low molecular weight derivatives: Basic and applied studies in the development of a new antithrombotic drug. Uppsala: Sveriges Lantbruksuniversitet, 1987.

Maccarana, Marco. O-sulfate groups in heparin and heparan sulfate: Formation and roles in protein building. Uppsala: University of Uppsala, 1994.

Westman, Jacob. Synthesis of oligosaccharides related to heparin and heparan sulphate and their binding to fibroblast growth factors. Stockholm, Sweden: Dept. of Organic Chemistry, Arrhenius Laboratory, Stockholm University, 1995.

Neisius, Petra. Niedermolekulares Heparin und Standard-Heparin im klinischen Vergleich: Eine Untersuchung zur Wirksamkeit, Verträglichkeit und laborchemischen Kontrolle der Low-dose-Heparin-Prophylaxe thrombembolischer Komplikationen in der Chirurgie. [s.l.]: [s.n.], 1988.

Hyers, Thomas M. Treatment handbook of low-molecular-weight heparin. London: Science Press, 2000.

Kimmerle, Inge. Untersuchungen zur enzymatischen Inaktivierung des Gerinnungshemmers Heparin. Hohenheim: [s.n.], 1986.

1949-, Lane D. A., e Lindahl Ulf 1939-, a cura di. Heparin: Chemical and biological properties, clinical applications. Boca Raton, Fla: CRC Press, 1989.

Khaliq, Yasmin. Clinical significance of the nitroglycerin-heparin interaction. [Ottawa, Ont.?: s.n.], 1991.

A, Ofosu Frederick, Danishefsky Isidore, Hirsh Jack 1935- e New York Academy of Sciences., a cura di. Heparin and related polysaccharides: Structure and activities. New York, N.Y: New York Academy of Sciences, 1989.

Lantbruksuniversitet, Sveriges, a cura di. Formation and degradation of the Heparin proteoglycan. Uppsala: Sveriges Lantbruksuniversitet, 1986.

Maguire, Jacinta Marie. Low molecular weight heparin regime or unfractionated heparin and as pirin in the treatment of unstable angina. [S.l: The Author], 1994.

Ettelaie, Cammile. Interaction of Heparin with antithombin III and polycations. Salford: University of Salford, 1987.

Tierney, David Patrick. The fractionation and characterisation of commercial heparin preparations. Salford: University of Salford, 1986.

1968-, Oremus Mark, United States. Agency for Healthcare Research and Quality. e McMaster University. Evidence-based Practice Center., a cura di. The uses of heparin to treat burn injury. Rockville, MD: AHRQ, 2006.

Lidholt, Kerstin. A new model for the biosynthesis of heparin. Uppsala: Swedish University of Agricultural Sciences, Faculty of Veterinary Medical Chemistry, Dept. of Veterinary Medical Chemistry, 1991.

Sharma, Anupama. A comparison of the binding abilities of human kidney heparan sulphate and heparin glycosaminoglycans for antithrombin III. Manchester: University of Manchester, 1995.

Kovaliv, Bohdan. Heparyn i heparynoïdy y klinichniĭ praktyt͡s︡i. Lʹviv: Lʹvivsʹkyĭ derz͡h︡avnyĭ medychnyĭ universytet im. Danyla Halyt͡s︡koho, 2003.

Nimmerfall, Katja. Die Wirkung von Heparin auf die Thrombozytenfunktion beim Hund. Hannover: [s.n.], 1999.

Grootjans, Jan Johann. Cytoplasmic interactions of the syndecans. Leuven: Leuven University Press, 2000.

International Fraxiparine Symposium (1st 1987 Paris, France). Fraxiparine: First international symposium : analytical and structural data, pharmacology, clinical trials. A cura di Fareed Jawed, Samama Meyer M e Breddin K. 1928-. Stuttgart: Schattauer, 1989.

(Editor), Hari G. Garg, Robert J. Linhardt (Editor) e Charles A. Hales (Editor), a cura di. Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier Science, 2005.

Garg, Hari G., Charles A. Hales e Robert J. Linhardt. Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier Science & Technology Books, 2011.

Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier, 2005. http://dx.doi.org/10.1016/b978-0-08-044859-6.x5000-x.

(Editor), Hari G. Garg, Robert J. Linhardt (Editor) e Charles A. Hales (Editor), a cura di. Chemistry and Biology of Heparin and Heparan Sulfate. Elsevier Science, 2005.

Richer, Monique. Monitoring heparin therapy with the heparin assay. 1989.

Greinacher, Andreas, e Theodore Warkentin. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2003.

Warkentin, Theodore, a cura di. Heparin-Induced Thrombocytopenia. Informa Healthcare, 2003. http://dx.doi.org/10.1201/9780203027363.

Warkentin, Theodore. Heparin-Induced Thrombocytopenia. CRC Press, 2003. http://dx.doi.org/10.1201/9780824758844.

Warkentin, Theodore E., e Andreas Greinacher, a cura di. Heparin-Induced Thrombocytopenia. CRC Press, 2007. http://dx.doi.org/10.1201/b21615.

Heparin-Binding Proteins. Elsevier, 1998. http://dx.doi.org/10.1016/b978-0-12-186060-8.x5000-1.

Warkentin, Theodore E., e Andreas Greinacher, a cura di. Heparin-Induced Thrombocytopenia. CRC Press, 2007. http://dx.doi.org/10.3109/9781420045093.

Heparin-Induced Thrombocytopenia. CRC Press LLC, 2003.

Heparin-binding proteins. San Diego: Academic Press, 1998.

Warkentin, Theodore E. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2003.

Greinacher, Andreas, e Theodore Warkentin. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2012.

Greinacher, Andreas, e Theodore Warkentin. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2001.